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Introduction
Clostridium difficile infection (CDI) is usually
caused by the administration of antibiotics that causes the
disruption of normal flora in the gut allowing for
colonization of C difficile in the intestines (Aziz, 2013).
CDI can cause diarrhea and may progress into colitis,
toxic mega colon, sepsis, or even death (Headley, 2012).
CDI has become increasingly difficult and costly to treat
due to new hypervirulent strains, causing an increase in
morbidity and mortality. The average cost of treating C
difficile is $5042 to $7179 per incident and national cost
of $897 million to $1.3 billion a year (Walters &
Zuckerbraun, 2014).
Healthcare acquired infections (HAI) have become a
national focus. They are considered preventable and can
be reduced with proper infection control practices,
surveillance, and appropriate antibiotic use. In 2009, the
U.S Department of Health and Human Services released
a plan to reduce all HAIs, which causes increased length
of stay, healthcare costs, and deaths. Most of the HAIs
have dramatically declined, but unfortunately CDIs still
remain high (Headley, 2012). Since 2013, acute care
hospitals have been required to report CDIs to the Center
for Medicaid and Medicare Services (CMS), which has
resulted in an increase awareness of infection control
practices and feedback on their current practice,
providing opportunities for improvement. The purpose of
this poster is to provide information on the
pathophysiology of CDIs and practitioners’ role in
reducing the incidence of CDIs.

The pathophysiology is significant because the toxins produced by C.
Difficile causes severe inflammation in the bowel and can lead to
pseudomembrane colitis. The severe cases of colitis increase the risk for
further complications, like toxic mega colon, perforated bowel and peritonitis
(Nazarko, 2015). These toxins can also cause a systemic effect that can lead to
sepsis and death (Walters & Zuckerbraun, 2014).

Symptoms
C. difficile colitis can have a wide range of symptoms that varies in the severity
Symptoms can occur during antibiotic therapy or up to 10 weeks after completing antibiotic
treatment.
May be asymptomatic
Abdominal pain and tenderness
watery diarrhea lasting greater than 48 hours
Elevated white blood cell count
Fever
Dehydration
Hypotension
Tachycardia
Loss of appetite
Mental Status changes
Lactic acidosis
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•
•
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Underlying Pathophysiology
Clostridium difficile is a gram-positive anaerobe that
produces spores and toxins. CDI usually occurs after an
individual’s intestinal microbiota is interrupted, usually
following antibiotic administration. The antibiotics destroy
the normal microbiota, which normally functions to
prevent infections and overgrowth, allowing the c. difficile
bacteria to grow (Wu, et al. 2013). C. difficile spores are
transmitted through the fecal- oral route. Upon entering
the gut, the bacteria enter the mucosal layer of the
epithelial layer and produce toxin A and toxin B, causing a
severe inflammatory response. (Buonom & Petri, 2016).
Toxin A and toxin B “are able to glucosylate and
inactivate Rho and Ras family small GTPases causing
disruption of the actin cytoskeleton causing disruption of
the actin cytoskeleton, cell rounding, inhibition of cell
division and cell death” (Buonom & Petri, 2016). The
inactivation of Rho and Ras causes degranulation by the
cytoskeleton, resulting in cell shrinkage and aptosis.
(Walters & Zuckerbraun). This causes epithelial
breakdown and loss of intestinal barrier, allowing for
bacteria to enter the lamina propria, which causes
inflammatory mediators and immune cells travel to the site.
Neutrophils travel to the site and are found in the
pseudomembranous lesions. Although neutrophils are the
main cell to fight CDI, it is suspected they may also
worsen colitis by causing damage to surrounding tissue
(Buonom & Petri, 2016).

Conclusion

Significance of
Pathophysiology

•
•

•
•

Figure 1 Toxic megacolon xray

A patient with suspected or confirmed CDI should be immediately placed in a private
room with enteric precautions to prevent the spread to others (Headley, 2012).
Gloves and gown are absolutely necessary, even when in not direct contact with the
individual.
Alcohol based sanitizers do not remove spores completely, so hand washing with soap
and water for 15 seconds must be done after removing gloves every time (Aziz, 2013).
The infected room must be cleaned daily with a bleach solution because other cleaners
are infective in killing the spores, which can live on surfaces for months (Headley, 2012).
The care provider should teach the patient and family about infection control practices to
reduce the risk of contracting CDI.
The main goal is prevention and early identification of CDI.
Antibiotic use disrupts the normal flora and sets up a perfect opportunity for CDI.
The appropriate and discriminate use of antibiotics is paramount to prevention (Walters &
Zuckerbarun, 2014).
Vancomycin intravenous administration within the previous eight weeks increase the risk
of CDI (Aldrete, et al., 2015).
Patients at an increase risk should be identified and monitored closely for symptoms.
Some risk factors include:

Age > 65 years old

Recent antibiotic use

Hospitalization

Comorbidities

Nasogastric tubes

Proton pump inhibitors (Narako, 2015)
A stool specimen should be obtained and sent for a PCR test, if there are 2 or more loose
stools in 24 hours.
Monitor for further complications of CDI, like toxic megacolon, perforated bowel,
peritonitis, or sepsis.

Clostridium difficile infection have been
increasing and is the most common health care
acquired infections (Bunomo & Petri, 2016). C
difficile colitis can lead to many complications that are
very costly and lead to significant increase in length of
stay. There are many opportunities in the acute care
setting to reduce the rate of health care acquired CDI.
As with many bacteria, C Difficile is becoming more
resistant to treatment. The inappropriate and over
use of antibiotics is a major reason why there has
been an increase in the cases and resistance of c
difficile to treatment. This should be addressed
daily with each patient to determine if they are
receiving the right antibiotics based off cultures
and symptoms. The need for quick identification and
diagnosis is key to prevent further complications and
strict infection control practices to prevent the further
spread.
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